NO974089D0 - Stimulering av meiose - Google Patents

Stimulering av meiose

Info

Publication number
NO974089D0
NO974089D0 NO974089A NO974089A NO974089D0 NO 974089 D0 NO974089 D0 NO 974089D0 NO 974089 A NO974089 A NO 974089A NO 974089 A NO974089 A NO 974089A NO 974089 D0 NO974089 D0 NO 974089D0
Authority
NO
Norway
Prior art keywords
meiosis
stimulation
Prior art date
Application number
NO974089A
Other languages
English (en)
Norwegian (no)
Other versions
NO974089L (no
Inventor
Erling Guddal
Anne Grete Byskov
Frederik Christian Groenvald
Lars Nordholm
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO974089L publication Critical patent/NO974089L/no
Publication of NO974089D0 publication Critical patent/NO974089D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/061—Sperm cells, spermatogonia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO974089A 1995-03-06 1997-09-05 Stimulering av meiose NO974089D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK23295 1995-03-06
DK30995 1995-03-24
PCT/DK1996/000093 WO1996027658A1 (fr) 1995-03-06 1996-03-06 Stimulation de la meiose

Publications (2)

Publication Number Publication Date
NO974089L NO974089L (no) 1997-09-05
NO974089D0 true NO974089D0 (no) 1997-09-05

Family

ID=26063579

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974089A NO974089D0 (no) 1995-03-06 1997-09-05 Stimulering av meiose

Country Status (13)

Country Link
US (1) US5830757A (fr)
EP (1) EP0813595A1 (fr)
JP (1) JPH11501806A (fr)
KR (1) KR19980702624A (fr)
AU (1) AU717180B2 (fr)
BR (1) BR9607673A (fr)
CA (1) CA2214126A1 (fr)
CZ (1) CZ279797A3 (fr)
HU (1) HUP9800731A3 (fr)
NO (1) NO974089D0 (fr)
PL (1) PL322106A1 (fr)
RU (1) RU2188006C2 (fr)
WO (1) WO1996027658A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746878B2 (en) * 1996-12-20 2002-05-02 Novo Nordisk A/S Meiosis regulating compounds
HUP0002331A3 (en) * 1997-05-16 2001-05-28 Akzo Nobel Nv 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
DK0988312T3 (da) * 1997-06-04 2002-07-15 Akzo Nobel Nv 17beta-allyloxy(thio)alkyl-androstanderivater til modulering af meiose
JP2001526293A (ja) 1997-12-18 2001-12-18 アクゾ・ノベル・エヌ・ベー １７β−アリール（アリールメチル）オキシ（チオ）アルキル−アンドロスタン誘導体
EP0957108A1 (fr) * 1998-05-14 1999-11-17 Schering Aktiengesellschaft Dérivés insaturés de cholestane pour la régulation de meiose et les compositions pharmaceutiques les contenant
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
CA2333320A1 (fr) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft Traitement de l'infertilite par des composes stimulant la production d'ampc, seuls ou associes a au moins un compose stimulant la meiose
JP2003521444A (ja) * 1998-06-19 2003-07-15 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
CA2352337A1 (fr) 1998-12-11 2000-06-22 Akzo Nobel Nv Derives de 22s-hydroxycholesta-8, 14-diene a activite regulatrice de la meiose
CN1368977A (zh) * 1999-02-10 2002-09-11 舍林股份公司 不饱和胆甾烷衍生物及其在制备调节减数分裂的药物中的应用
DE60034662T2 (de) 1999-02-24 2008-01-03 Novo Nordisk A/S Behandlung von unfruchtbarkeit
HUP0200157A3 (en) 1999-02-24 2002-06-28 Novo Nordisk As Treatment of infertility
HUP0200201A3 (en) * 1999-02-26 2002-06-28 Schering Ag Meiosis activating sterol augments implantation rate
JP2002539134A (ja) * 1999-03-09 2002-11-19 アクゾ・ノベル・エヌ・ベー 減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体
AU4756100A (en) * 1999-05-10 2000-11-21 Schering Aktiengesellschaft 14beta-h-sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
CZ2002591A3 (cs) 1999-09-16 2002-08-14 Novo Nordisk A/S Pevný produkt, prostředek, vodný roztok a zaváděcí systém
EP1127890A1 (fr) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Stéroides avec un cycle condensés au cycle A du noyau stéroide pour la régulation de la méiose
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
EP1216701A1 (fr) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Procédé pour augmenter la concentration de sterols activant la meiose dans la synthèse du cholesterol et utilisation d'inhiteurs puissants dans le procédé
EP1245572A1 (fr) * 2001-03-26 2002-10-02 Schering Aktiengesellschaft Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
US20090105333A1 (en) * 2006-05-22 2009-04-23 Gunther Birznieks Melatonin agonist treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols

Also Published As

Publication number Publication date
NO974089L (no) 1997-09-05
AU717180B2 (en) 2000-03-16
AU4784596A (en) 1996-09-23
PL322106A1 (en) 1998-01-05
HUP9800731A2 (hu) 1998-07-28
KR19980702624A (ko) 1998-08-05
US5830757A (en) 1998-11-03
WO1996027658A1 (fr) 1996-09-12
CA2214126A1 (fr) 1996-09-12
CZ279797A3 (cs) 1998-01-14
RU2188006C2 (ru) 2002-08-27
EP0813595A1 (fr) 1997-12-29
HUP9800731A3 (en) 2000-03-28
BR9607673A (pt) 1998-06-16
MX9706565A (es) 1997-11-29
JPH11501806A (ja) 1999-02-16

Similar Documents

Publication Publication Date Title
NO974089D0 (no) Stimulering av meiose
DE69630335D1 (de) Implantierbarer Herzschrittmacher
DE69602011D1 (de) Implantierbare stimulationselektroden
NO973928L (no) Behandling av oljebrönn
DE19680452T1 (de) Massagegerät
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
NO955356D0 (no) Behandling av hypotalamisk amenorre
DE59609250D1 (de) Stimulationssystem
DE69631727D1 (de) Implantierbarer Herzschrittmacher
NO975565D0 (no) Ben stimulerende faktor
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO980862D0 (no) Zwitterinoformer av trovafloxacin
FR2736272B1 (fr) Stimulateur lombo-abdominal
NO964685L (no) Isomering av equilin
SE9504332D0 (sv) Pacemaker
KR960028276U (ko) 목욕용 브러쉬 세트
KR970027099U (ko) 안마기
FI950355A0 (fi) Foerfarande foer taeckande av soetheten i mjoelkprodukt
KR960036072U (ko) 장신구의 엘레멘트
UA1112S (uk) Мікро-еом широкого призначення
ITTV950114A0 (it) Struttura di tavolino-sgabello
KR970041939U (ko) 부품의 방진체결구조
BR9501953A (pt) Estimulador facial
NO952526D0 (no) Metoder for behandling av reumatisme
FI940970A0 (fi) Neutralisering av saopa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application